Aptinyx Presents Preclinical Data on NMDA Receptor Modulator NYX-2925 at the International Association for the Study of Pain’s 17th World Congress on Pain

World News: . []

EVANSTON Ill Sept 14 2018 GLOBE NEWSWIRE -- Aptinyx IncNASDAQAPTX a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the presentatio n of tw...

More news and information about Aptinyx Inc.

Published By:

Globe Newswire: 13:07 GMT Friday 14th September 2018

Published: .

Search for other references to "aptinyx" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us